Central Nervous System Drugs Global Market Report 2022

Central Nervous System Drugs Global Market Report 2022 – By Type (Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

Name: Central Nervous System Drugs Global Market Report 2022
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Central Nervous System Drugs Global Market Report 2022

Starting Price : $4000.00 $3200.00 | Pages : 300 | Published : March 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

The central nervous system (CNS) drugs market consists of sales of central nervous system drugs and related services by entities (organizations, sole traders and partnerships) that manufacture central nervous system drugs that are used in the treatment of diseases affecting the brain or spinal cord. The central nervous system integrates sensory information and instructs the body to respond accordingly. The spinal cord is a channel for signals between the brain and the rest of the body. CNS disorder is a condition in which the brain and spinal cord’s ability to function is affected, hence affecting the body. The market for CNS disorder drugs comprises of drugs that work in different ways depending on the type of disease by suppressing or boosting the brain activities

The main types of central nervous system (CNS) drugs are analgesics, anti-parkinson drugs, anesthetics, anti-epileptics and other CNS drugs. Analgesics, also known as painkillers, are medications that alleviate various types of pain, ranging from headaches to injuries to arthritis. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores and others.

The global central nervous system drugs market size is expected to grow from $169.11 billion in 2021 to $178.70 billion in 2022 at a compound annual growth rate (CAGR) of 5.7%. The growth in the CNS drugs market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The central nervous system drugs market is expected to reach $264.97 billion in 2026 at a CAGR of 10.3%.

The central nervous system drugs market will be driven by rapid growth in emerging markets in the forecast period. Emerging markets growth is aided by rising disposable income, stable political environment and increasing foreign investments in these countries. For instance, according to the IMF, China’s GDP growth rate was 2.3% in 2020., according to the World Economic Outlook Reports by the IMF, the global growth is 6% in 2021 and expected to be 4.4% in 2022. Thus, strong economic growth will boost the demand for central nervous system drugs and this will drive the market during the forecast period.

During the forecast period, the growth of the central nervous system drugs market will be restrained by patent expiration of branded central nervous system drugs. In general, pharmaceutical companies invest a large sum of money in the drug development process and patents. During the patency period, the company holding the patent holds exclusivity for the manufacturing and distribution of drugs. Post expiration of patency, generic versions of the drugs are manufactured by other companies with prices much lower than the original branded drugs. Overall, this will negatively impact the growth of the market in terms of value.

Many central nervous system drug manufacturers are collaborating with other manufacturers in the industry to share technical knowledge and improve product quality. These agreements are helping anti-epileptics drugs manufacturers broaden their products and services. For instance, in March 2021, SEQENS and Rondol Group had announced a collaboration in formulation research and continuous flow manufacturing for existing, repurposed, or new drugs for oncology, infectious diseases, and central nervous system disorders. In June 2021, DSM and Brains Bioceutical have established a global exclusive partnership to unlock the therapeutic potential of cannabinoids in early-stage drug development. The cannabinoid API market is rapidly expanding, fueled by strong scientific evidence demonstrating cannabinoid's potential in a variety of therapeutic areas, including Central Nervous System (CNS) diseases.

Major companies in the central nervous system drugs market include Biogen Inc, Johnson & Johnson, Novartis AG, UCB S.A., Takeda Pharmaceuticals, AbbVie, Teva Pharmaceuticals, GlaxosmithKline, Daiichi Sankyo Company and H Lundbeck.

North America was the largest region in the central nervous system drugs market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the CNS drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the central nervous system drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam.

The global central nervous system drugs market is segmented -

1) By Type: Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Other CNS Drugs

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

Book your 30 minutes free consultation with our research experts

1. Central Nervous System Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

6.1. Segmentation By Geography

6.2. Segmentation By Type

6.3. Segmentation By Distribution Channel

6.4. Segmentation By Route Of Administration

6.5. Segmentation By Drug Classification

6.6. Segmentation By Mode Of Purchase

7. Central Nervous System Drugs Market Characteristics

7.1. Market Definition

7.2. Market Segmentation By Type

7.2.1. Multiple Sclerosis (MS)

7.2.2. Anti-Psychotic

7.2.3. Analgesics

7.2.4. Anti-Parkinson Drugs

7.2.5. Anesthetics

7.2.6. Anti-Epileptics

7.2.7. Anti-Depressants

7.2.8. Other CNS Drugs

7.3. Market Segmentation By Distribution Channel

7.3.1. Hospitals Pharmacies

7.3.2. Retail Pharmacies/ Drug Stores

7.3.3. Others

7.4. Market Segmentation By Route Of Administration

7.4.1. Oral

7.4.2. Intravenous

7.4.3. Intranasal/ Inhalation

7.4.4. Others

7.5. Market Segmentation By Drug Classification

7.5.1. Branded Drugs

7.5.2. Generic Drugs

7.6. Market Segmentation By Mode Of Purchase

7.6.1. Over-The-Counter Drugs

7.6.2. Prescription-Based Drugs

8. Central Nervous System Drugs Market, Supply Chain Analysis

8.1. Supply Chain

8.1.1. Raw Material Suppliers

8.1.2. Contract Research Organization (CRO)

8.1.3. Central Nervous System Drugs Manufacturer

8.1.4. Contract Manufacturing Organization (CMO)

8.2. Distribution

8.2.1. Wholesalers/Distributors

8.2.2. Retailers (Pharmacies) And Hospitals

8.2.3. Neurologists

8.3. End-Users

9. Central Nervous System Drugs Market, Product Analysis – Product Examples

10. Central Nervous System Drugs Market Customer Information

10.1. Usage of Central Nervous System Medicines In Old Age Homes

10.2. Study On Effectiveness Of Anti-Depressants

10.3. Lower Approval Rates For Central Nervous System Drugs

11. Central Nervous System Drugs Market Trends And Strategies

11.1. Wearables To Improve R&D

11.2. Biomarkers In CNS Drug Development

11.3. Modification Of Existing Epilepsy Drugs

11.4. Collaborations For CNS Drug Development

11.5. Drug Pipeline

11.6. 3D Printing Technology

12. Leading Central Nervous System Drugs

13. Pipeline Drugs

14. Impact Of COVID-19 On The Central Nervous System Drugs Market

14.1. Clinical Trial Delays

14.2. Supply Chain Issues

14.3. Increasing Demand For Anti-Depressants Due To COVID-19

14.4. Future Outlook

15. Global Central Nervous System Drugs Market Size And Growth

15.1. Market Size

15.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

15.2.1. Drivers Of The Market 2015 – 2020

15.2.2. Restraints On The Market 2015 – 2020

15.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

15.3.1. Drivers Of The Market 2020 – 2025

15.3.2. Restraints On The Market 2020 – 2025

16. Central Nervous System Drugs Market, Regional Analysis

16.1. Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16.2. Global Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Region

16.3. Global Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region

17. Global Central Nervous System Drugs Market Segmentation

17.1. Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.1.1. Multiple Sclerosis

17.1.2. Other CNS drugs

17.1.3. Anti-Psychotic

17.1.4. Anti-Epileptics

17.1.5. Antidepressants

17.1.6. Anesthetics

17.1.7. Analgesics

17.1.8. Anti-Parkinson drugs

17.2. Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.2.1. Hospital Pharmacies

17.2.2. Retail Pharmacies/ Drug Stores

17.2.3. Other Distribution Channel

17.3. Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.3.1. Oral

17.3.2. Intravenous

17.3.3. Intranasal

17.3.4. Others

17.4. Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.4.1. Branded Drugs

17.4.2. Generic Drugs

17.5. Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.5.1. Prescription-Based Drugs

17.5.2. Over-The-Counter Drugs

18. Global Central Nervous System Drugs Market Metrics

18.1. Central Nervous System Drugs Market Size, Percentage Of GDP, Global

18.2. Per Capita Average Central Nervous System Drugs Market Expenditure, Global

19. Asia-Pacific Central Nervous System Drugs Market

19.1. Asia-Pacific Central Nervous System Drugs Market Overview

19.1.1. Region Information

19.1.2. Market Information

19.1.3. COVID-19 Impact

19.1.4. Background Information

19.1.5. Government Initiatives

19.1.6. Regulations

19.1.7. Regulatory Bodies

19.1.8. Major Associations

19.1.9. Taxes Levied

19.1.10. Corporate Tax Structure

19.1.11. Investments

19.1.12. Major Companies

19.2. Asia-Pacific Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.3. Asia-Pacific Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.4. Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19.5. Asia-Pacific Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

19.6. Asia-Pacific Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

19.7. Asia-Pacific Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

19.8. Asia-Pacific Central Nervous System Drugs Market Metrics

19.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Asia-Pacific Major Countries

19.9. Asia-Pacific Central Nervous System Drugs Market: Country Analysis

19.10. Australia Central Nervous System Drugs Market

19.11. Australia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.12. Australia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.13. Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19.14. China Central Nervous System Drugs Market

19.15. China Central Nervous System Drugs Market Overview

19.15.1. Country Information

19.15.2. Market Information

19.15.3. COVID-19 Impact

19.15.4. Background Information

19.15.5. Government Initiatives

19.15.6. Regulations

19.15.7. Regulatory Bodies

19.15.8. Major Associations

19.15.9. Taxes Levied

19.15.10. Corporate Tax Structure

19.15.11. Investments

19.15.12. Major Companies

19.16. China Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.17. China Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.18. China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19.19. Hong Kong Central Nervous System Drugs Market

19.20. Hong Kong Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.21. Hong Kong Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.22. India Central Nervous System Drugs Market

19.23. India Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.24. India Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.25. India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19.26. Indonesia Central Nervous System Drugs Market

19.27. Indonesia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.28. Indonesia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.29. Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19.30. Japan Central Nervous System Drugs Market

19.31. Japan Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.32. Japan Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.33. Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19.34. Malaysia Central Nervous System Drugs Market

19.35. Malaysia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.36. Malaysia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.37. New Zealand Central Nervous System Drugs Market

19.38. New Zealand Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.39. New Zealand Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.40. Philippines Central Nervous System Drugs Market

19.41. Philippines Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.42. Philippines Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.43. Singapore Central Nervous System Drugs Market

19.44. Singapore Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.45. Singapore Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.46. South Korea Central Nervous System Drugs Market

19.47. South Korea Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.48. South Korea Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.49. South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19.50. Thailand Central Nervous System Drugs Market

19.51. Thailand Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.52. Thailand Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.53. Vietnam Central Nervous System Drugs Market

19.54. Vietnam Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.55. Vietnam Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20. Western Europe Central Nervous System Drugs Market

20.1. Western Europe Central Nervous System Drugs Market Overview

20.1.1. Region Information

20.1.2. Market Information

20.1.3. COVID Impact

20.1.4. Background Information

20.1.5. Government Initiatives

20.1.6. Regulations

20.1.7. Regulatory Bodies

20.1.8. Major Associations

20.1.9. Taxes Levied

20.1.10. Corporate Tax Structure

20.1.11. Investments

20.1.12. Major Companies

20.2. Western Europe Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.3. Western Europe Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.4. Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

20.5. Western Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

20.6. Western Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

20.7. Western Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

20.8. Western Europe Central Nervous System Drugs Market Metrics

20.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Western Europe Major Countries

20.9. Western Europe Central Nervous System Drugs Market: Country Analysis

20.10. Austria Central Nervous System Drugs Market

20.11. Austria Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.12. Austria Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.13. Belgium Central Nervous System Drugs Market

20.14. Belgium Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.15. Belgium Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.16. Denmark Central Nervous System Drugs Market

20.17. Denmark Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.18. Denmark Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.19. Finland Central Nervous System Drugs Market

20.20. Finland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.21. Finland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.22. France Central Nervous System Drugs Market

20.23. France Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.24. France Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.25. France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

20.26. Germany Central Nervous System Drugs Market

20.27. Germany Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.28. Germany Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.29. Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

20.30. Ireland Central Nervous System Drugs Market

20.31. Ireland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.32. Ireland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.33. Italy Central Nervous System Drugs Market

20.34. Italy Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.35. Italy Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.36. Netherlands Central Nervous System Drugs Market

20.37. Netherlands Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.38. Netherlands Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.39. Norway Central Nervous System Drugs Market

20.40. Norway Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.41. Norway Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.42. Portugal Central Nervous System Drugs Market

20.43. Portugal Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.44. Portugal Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.45. Spain Central Nervous System Drugs Market

20.46. Spain Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.47. Spain Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.48. Sweden Central Nervous System Drugs Market

20.49. Sweden Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.50. Sweden Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.51. Switzerland Central Nervous System Drugs Market

20.52. Switzerland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.53. Switzerland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.54. UK Central Nervous System Drugs Market

20.55. UK Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.56. UK Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.57. UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

21. Eastern Europe Central Nervous System Drugs Market

21.1. Eastern Europe Central Nervous System Drugs Market Overview

21.1.1. Region Information

21.1.2. Market Information

21.1.3. COVID Impact

21.1.4. Background Information

21.1.5. Government Initiatives

21.1.6. Regulations

21.1.7. Regulatory Bodies

21.1.8. Major Associations

21.1.9. Taxes Levied

21.1.10. Corporate Tax Structure

21.1.11. Investments

21.1.12. Major Companies

21.2. Eastern Europe Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

21.3. Eastern Europe Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

21.4. Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

21.5. Eastern Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

21.6. Eastern Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

21.7. Eastern Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

21.8. Eastern Europe Central Nervous System Drugs Market Metrics

21.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Eastern Europe Major Countries

21.9. Eastern Europe Central Nervous System Drugs Market: Country Analysis

21.10. Czech Republic Central Nervous System Drugs Market

21.11. Czech Republic Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

21.12. Czech Republic Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

21.13. Poland Central Nervous System Drugs Market

21.14. Poland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

21.15. Poland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

21.16. Romania Central Nervous System Drugs Market

21.17. Romania Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

21.18. Romania Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

21.19. Russia Central Nervous System Drugs Market

21.20. Russia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

21.21. Russia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

21.22. Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

22. North America Central Nervous System Drugs Market

22.1. North America Central Nervous System Drugs Market Overview

22.1.1. Region Information

22.1.2. Market Information

22.1.3. COVID-19 Impact

22.1.4. Background Information

22.1.5. Government Initiatives

22.1.6. Regulations

22.1.7. Regulatory Bodies

22.1.8. Investments

22.1.9. Major Associations

22.1.10. Tax Levied

22.1.11. Corporate Tax Structure

22.1.12. Major Companies

22.2. North America Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

22.3. North America Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

22.4. North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

22.5. North America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

22.6. North America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

22.7. North America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

22.8. North America Central Nervous System Drugs Market Metrics

22.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, North America Major Countries

22.9. North America Central Nervous System Drugs Market: Country Analysis

22.10. Canada Central Nervous System Drugs Market

22.11. Canada Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

22.12. Canada Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

22.13. Mexico Central Nervous System Drugs Market

22.14. Mexico Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

22.15. Mexico Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

22.16. USA Central Nervous System Drugs Market

22.17. USA Central Nervous System Drugs Market Overview

22.17.1. Country Information

22.17.2. Market Information

22.17.3. COVID-19 Impact

22.17.4. Background Information

22.17.5. Government Initiatives

22.17.6. Regulations

22.17.7. Regulatory Bodies

22.17.8. Investments

22.17.9. Major Associations

22.17.10. Corporate Tax Structure

22.17.11. Major Companies

22.18. USA Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

22.19. USA Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

22.20. USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

23. South America Central Nervous System Drugs Market

23.1. South America Central Nervous System Drugs Market Overview

23.1.1. Region Information

23.1.2. Market Information

23.1.3. COVID-19 Impact

23.1.4. Background Information

23.1.5. Regulations

23.1.6. Regulatory Bodies

23.1.7. Investments

23.1.8. Major Associations

23.1.9. Tax Levied

23.1.10. Corporate Tax Structure

23.1.11. Major Companies

23.2. South America Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

23.3. South America Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

23.4. South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

23.5. South America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

23.6. South America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

23.7. South America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

23.8. South America Central Nervous System Drugs Market Metrics

23.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, South America Major Countries

23.9. South America Central Nervous System Drugs Market: Country Analysis

23.10. Argentina Central Nervous System Drugs Market

23.11. Argentina Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

23.12. Argentina Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

23.13. Brazil Central Nervous System Drugs Market

23.14. Brazil Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

23.15. Brazil Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

23.16. Brazil Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

23.17. Chile Central Nervous System Drugs Market

23.18. Chile Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

23.19. Chile Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

23.20. Colombia Central Nervous System Drugs Market

23.21. Colombia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

23.22. Colombia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

23.23. Peru Central Nervous System Drugs Market

23.24. Peru Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

23.25. Peru Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

23.26. Venezuela Central Nervous System Drugs Market

23.27. Venezuela Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

23.28. Venezuela Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

24. Middle East Central Nervous System Drugs Market

24.1. Middle East Central Nervous System Drugs Market Overview

24.1.1. Region Information

24.1.2. Market Information

24.1.3. COVID-19 Impact

24.1.4. Background Information

24.1.5. Government Initiatives

24.1.6. Regulations

24.1.7. Regulatory Bodies

24.1.8. Major Associations

24.1.9. Taxes Levied

24.1.10. Corporate Tax Structure

24.1.11. Investments

24.1.12. Major Companies

24.2. Middle East Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

24.3. Middle East Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

24.4. Middle East Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

24.5. Middle East Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

24.6. Middle East Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

24.7. Middle East Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

24.8. Middle East Central Nervous System Drugs Market Metrics

24.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Middle East Major Countries

24.9. Middle East Central Nervous System Drugs Market: Country Analysis

24.10. Israel Central Nervous System Drugs Market

24.11. Israel Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

24.12. Israel Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

24.13. Saudi Arabia Central Nervous System Drugs Market

24.14. Saudi Arabia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

24.15. Saudi Arabia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

24.16. Turkey Central Nervous System Drugs Market

24.17. Turkey Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

24.18. Turkey Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

24.19. UAE Central Nervous System Drugs Market

24.20. UAE Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

24.21. UAE Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

25. Africa Central Nervous System Drugs Market

25.1. Africa Central Nervous System Drugs Market Overview

25.1.1. Region Information

25.1.2. Market Information

25.1.3. COVID-19 Impact

25.1.4. Background Information

25.1.5. Government Initiatives

25.1.6. Regulations

25.1.7. Regulatory Bodies

25.1.8. Major Associations

25.1.9. Taxes Levied

25.1.10. Corporate Tax Structure

25.1.11. Investments

25.1.12. Major Companies

25.2. Africa Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

25.3. Africa Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

25.4. Africa Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

25.5. Africa Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

25.6. Africa Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

25.7. Africa Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

25.8. Africa Central Nervous System Drugs Market Metrics

25.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Africa Major Countries

25.9. Africa Central Nervous System Drugs Market: Country Analysis

25.10. Egypt Central Nervous System Drugs Market

25.11. Egypt Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

25.12. Egypt Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

25.13. Nigeria Central Nervous System Drugs Market

25.14. Nigeria Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

25.15. Nigeria Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

25.16. South Africa Central Nervous System Drugs Market

25.17. South Africa Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

25.18. South Africa Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

26. Global Central Nervous System Drugs Market Competitive Landscape

26.1. Biogen Inc.

26.1.1. Company Overview

26.1.2. Products And Services

26.1.3. Business Strategy

26.1.4. Financial Overview

26.2. Johnson & Johnson

26.2.1. Company Overview

26.2.2. Products And Services

26.2.3. Business Strategy

26.2.4. Financial Overview

26.3. Hoffmann-La Roche Ltd

26.3.1. Company Overview

26.3.2. Products And Services

26.3.3. Business Strategy

26.3.4. Financial Overview

26.4. Novartis AG

26.4.1. Company Overview

26.4.2. Products And Services

26.4.3. Business Strategy

26.4.4. Financial Overview

26.5. UCB

26.5.1. Company Overview

26.5.2. Products And Services

26.5.3. Business Strategy

26.5.4. Financial Overview

27. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

27.1. Ethypharm Acquired Altan Pharma

27.2. Angelini Pharma Acquired Arvelle Therapeutics

27.3. Novartis Acquired Cadent Therapeutics

27.4. Biogen Acquired Sangamo Therapeutics

27.5. Supernus Acquired US WorldMeds

27.6. Permira Acquired Neuraxpharm

27.7. UCB Acquired Handl Therapeutics

27.8. Neurocrine Biosciences Acquired Voyager Therapeutics

27.9. Eli Lilly Acquired Loxo Oncology Inc.

27.10. Neuraxpharm Acquired Farmax

27.11. CNS Pharmaceuticals Acquired Houston Pharmaceuticals Inc.

27.12. H. Lundbeck Acquired Prexton Therapeutics

27.13. Novartis Acquired AveXis

27.14. Biolab Pharma Acquired Avtavis Brazil

27.15. Mitsubishi Tanabe Pharma Acquired NeuroDerm

27.16. Eli Lilly Acquires CoLucid

27.17. Lupin Acquired Temmler Pharma

28. Market Background: Pharmaceutical Drugs Market

28.1. Pharmaceutical Drugs Market Characteristics

28.1.1. Market Definition

28.1.2. Segmentation By Type

28.2. Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 – 2025, Value ($ Billion)

28.3. Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)

28.4. Global Pharmaceutical Drugs Market, 2015 – 2025, Historic And Forecast, By Region

29. Central Nervous System Drugs Market Future Outlook and Potential Analysis

29.1. Global Central Nervous System Drugs Market In 2025 – Countries Offering Most New Opportunities

29.2. Global Central Nervous System Drugs Market In 2025 – Segments Offering Most New Opportunities

29.3. Global Central Nervous System Drugs Market In 2025 – Growth Strategies

29.3.1. Market Trend Based Strategies

29.3.2. Competitor Strategies

30. Appendix

30.1. Market Data Sources

30.2. NAICS Definitions Of Industry Covered In This Report

30.3. Research Methodology

30.4. Currencies

30.5. Research Inquiries

30.6. The Business Research Company

30.7. Copyright and Disclaimer

List Of Tables

Table 1 : Global Central Nervous System Drugs Market, Product Analysis – Product Examples

Table 2: Global Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 3: Global Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 4: Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Table 5: Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 6: Global Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region

Table 7: Global Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region

Table 8: Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 9: Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 10: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 11: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 12: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 13: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 14: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 15: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 16: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 17: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 18: Global Central Nervous System Drugs Market Value, Market Size As A Percentage Of Global GDP, 2015 – 2025

Table 19: Global Central Nervous System Drugs Market, Per Capita Average Central Nervous System Drugs Market Industry Expenditure, 2015 – 2025, ($)

Table 20: Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion

Table 21: Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion

Table 22: Asia-Pacific Per Capita Net Disposable Income, 2015-2019, $

Table 23: Asia Pacific Population By Age Group, 2015-2023, Thousands

Table 24: Asia-Pacific Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 25: Asia-Pacific Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 26: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 27: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 28: Asia-Pacific Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

Table 29: Asia-Pacific Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country

Table 30: Asia-Pacific Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

Table 31: Asia-Pacific Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $

Table 32: Australia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 33: Australia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 34: Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 35: Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 36: China Pharmaceuticals, 2015-2020, $ Billion

Table 37: China Public Healthcare Expenditure, 2015-2019, $ Billion

Table 38: China Private Healthcare Expenditure, 2015-2019, $ Billion

Table 39: China Per Capita Net Disposable Income, 2015-2019, $

Table 40: China Population By Age Group, 2015-2023, Thousands

Table 41: China Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 42: China Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 43: China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 44: China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 45: Hong Kong Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 46: Hong Kong Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 47: India Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 48: India Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 49: India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 50: India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 51: Indonesia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 52: Indonesia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 53: Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 54: Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 55: Japan Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 56: Japan Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 57: Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 58: Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 59: Malaysia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 60: Malaysia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 61: New Zealand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 62: New Zealand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 63: Philippines Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 64: Philippines Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 65: Singapore Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 66: Singapore Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 67: South Korea Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 68: South Korea Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 69: South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 70: South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 71: Thailand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 72: Thailand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 73: Vietnam Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 74: Vietnam Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 75: Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion

Table 76: Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion

Table 77: Western Europe Per Capita Net Disposable Income, 2015-2019, $

Table 78: Western Europe Population By Age Group, 2015-2023, Thousands

Table 79: Western Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 80: Western Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 81: Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 82: Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 83: Western Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

Table 84: Western Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country

Table 85: Western Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

Table 86: Western Europe Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $

Table 87: Austria Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 88: Austria Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 89: Belgium Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 90: Belgium Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 91: Denmark Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 92: Denmark Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 93: Finland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 94: Finland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 95: France Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 96: France Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 97: France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 98: France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 99: Germany Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 100: Germany Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 101: Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 102: Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 103: Ireland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 104: Ireland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 105: Italy Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 106: Italy Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 107: Netherlands Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 108: Netherlands Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 109: Norway Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 110: Norway Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 111: Portugal Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 112: Portugal Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 113: Spain Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 114: Spain Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 115: Sweden Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 116: Sweden Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 117: Switzerland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 118: Switzerland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 119: UK Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 120: UK Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 121: UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 122: UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 123: Eastern Europe Public Healthcare Expenditure, 2015-2019,$Billion

Table 124: Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion

Table 125: Eastern Europe Per Capita Net Disposable Income, 2015-2019, $

Table 126: Eastern Europe Population By Age Group, 2015-2023, Thousands

Table 127: Eastern Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 128: Eastern Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 129: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 130: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 131: Eastern Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

Table 132: Eastern Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country

Table 133: Eastern Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

Table 134: Eastern Europe Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $

Table 135: Czech Republic Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 136: Czech Republic Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 137: Poland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 138: Poland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 139: Romania Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 140: Romania Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 141: Russia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 142: Russia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 143: Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 144: Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 145: North America Public Healthcare Expenditure, 2015-2019, $ Billion

Table 146: North America Private Healthcare Expenditure, 2015-2019, $ Billion

Table 147: North America Per Capita Net Disposable Income, 2015-2019, $

Table 148: North America Population By Age Group, 2015-2023, Thousands

Table 149: North America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 150: North America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 151: North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 152: North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 153: North America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

Table 154: North America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country

Table 155: North America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

Table 156: North America Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $

Table 157: Canada Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 158: Canada Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 159: Mexico Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 160: Mexico Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 161: USA Public Healthcare Expenditure, 2015-2019, $ Billion

Table 162: USA Private Healthcare Expenditure, 2015-2019, $ Billion

Table 163: USA Per Capita Net Disposable Income, 2015-2019, $

Table 164: USA Market, Population By Age Group, 2015-2023, Thousands

Table 165: USA Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 166: USA Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 167: USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 168: USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 169: South America Public Healthcare Expenditure, 2015-2019, $ Billion

Table 170: South America Private Healthcare Expenditure, 2015-2019, $ Billion

Table 171: South America Per Capita Net Disposable Income, 2015-2019, $

Table 172: South America Population By Age Group, 2015-2023, Thousands

Table 173: South America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Table 174: South America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 175: South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 176: South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 177: South America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

Table 178: South America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country

Table 179: South America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

Table 180: South America Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $

List Of Figures

Figure 1: Global Central Nervous System Drugs Market Segmentation By Type

Figure 2: Global Central Nervous System Drugs Market Segmentation By Distribution Channel

Figure 3: Global Central Nervous System Drugs Market Segmentation By Route Of Administration

Figure 4: Global Central Nervous System Drugs Market Segmentation By Drug Classification

Figure 5: Global Central Nervous System Drugs Market Segmentation By Mode Of Purchase

Figure 6: Market Supply Chain For Central Nervous System Drugs

Figure 7: Global Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 8: Global Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 9: Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 10: Global Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region

Figure 11: Global Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region

Figure 12: Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 13: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 14: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 15: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 16: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 17: Asia-Pacific Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 18: Asia-Pacific Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 19: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 20: Asia-Pacific Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

Figure 21: Asia-Pacific Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country

Figure 22: Asia-Pacific Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

Figure 23: Australia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 24: Australia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 25: Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 26: China Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 27: China Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 28: China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 29: Hong Kong Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 30: Hong Kong Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 31: India Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 32: India Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 33: India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 34: Indonesia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 35: Indonesia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 36: Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 37: Japan Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 38: Japan Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 39: Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 40: Malaysia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 41: Malaysia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 42: New Zealand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 43: New Zealand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 44: Philippines Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 45: Philippines Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 46: Singapore Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 47: Singapore Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 48: South Korea Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 49: South Korea Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 50: South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 51: Thailand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 52: Thailand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 53: Vietnam Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 54: Vietnam Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 55: Western Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 56: Western Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 57: Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 58: Western Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

Figure 59: Western Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country

Figure 60: Western Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

Figure 61: Austria Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 62: Austria Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 63: Belgium Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 64: Belgium Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 65: Denmark Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 66: Denmark Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 67: Finland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 68: Finland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 69: France Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 70: France Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 71: France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 72: Germany Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 73: Germany Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 74: Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 75: Ireland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 76: Ireland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 77: Italy Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 78: Italy Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 79: Netherlands Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 80: Netherlands Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 81: Norway Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 82: Norway Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 83: Portugal Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 84: Portugal Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 85: Spain Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 86: Spain Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 87: Sweden Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 88: Sweden Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 89: Switzerland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 90: Switzerland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 91: UK Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 92: UK Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 93: UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 94: Eastern Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 95: Eastern Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 96: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 97: Eastern Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

Figure 98: Eastern Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country

Figure 99: Eastern Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

Figure 100: Czech Republic Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 101: Czech Republic Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 102: Poland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 103: Poland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 104: Romania Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 105: Romania Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 106: Russia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 107: Russia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 108: Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 109: North America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 110: North America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 111: North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 112: North America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

Figure 113: North America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country

Figure 114: North America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

Figure 115: Canada Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 116: Canada Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 117: Mexico Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 118: Mexico Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 119: USA Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 120: USA Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 121: USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 122: South America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 123: South America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 124: South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 125: South America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

Figure 126: South America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country

Figure 127: South America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

Figure 128: Argentina Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 129: Argentina Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 130: Brazil Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 131: Brazil Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 132: Brazil Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 133: Chile Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 134: Chile Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 135: Colombia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 136: Colombia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 137: Peru Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 138: Peru Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 139: Venezuela Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

Figure 140: Venezuela Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 141: Middle East Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

Analgesics Global Market Report 2024 – By Type (Non-opioids, Opioids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores), By Application (Internal Analgesics, External Analgesics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Antiemetics And Antinauseants Global Market Report 2024 – By Drug (Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types), By Application (Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types), By End Users (Hospital, Medical Center, Clinic, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Anti-Parkinson Drugs Global Market Report 2024 – By Drugs Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs ), By Route of Administration (Oral, Injection, Transdermal ), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Anesthetics Global Market Report 2024 – By Type (General Anesthetics, Local Anesthetics), By Route of Administration (Inhalation Anesthesia Drugs, Intravenous Anesthesia Drugs, Topical Anesthesia Drugs), By Application (General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Brain And Neuroimaging Devices Global Market Report 2024 – By Imaging Type (Functional Magnetic Resonance Imaging (fMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magneto Encephalography (MEG), Other Imaging Types), By Application (Parkinson’s Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders, Other Applications), By End-user (Hospitals, Diagnostic Centres, Ambulatory Surgical Centres) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Antibody Drug Conjugates Global Market Report 2024 – By Type (Monoclonal Antibodies, Linker, Drug/Toxin, Other Types), By Product (Adcertis, Kadcyla, Other Products), By Technology (Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Other Technology), By Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Other Applications), By End User (Hospital, Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Generic Pharmaceuticals Global Market Report 2024 – By Type (Biosimilars, Generics), By Drug Delivery (Oral, Injectables, Dermal/Topical, Inhaled), By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Brain Tumor Drugs Market 2022 - By Drugs (Temozolomide, Bevacizumab), By End User (Hospital Pharmacies, Retail Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the central nervous system drugs market?

The central nervous system (CNS) drugs market consists of sales of central nervous system drugs and related services by entities that manufacture central nervous system drugs that are used in the treatment of diseases affecting the brain or spinal cord request a sample here

How will the central nervous system drugs market drivers and restraints affect central nervous system drugs market dynamics? What forces will shape the central nervous system drugs industry going forward?

The central nervous system (CNS) drugs market growth is aided by rapid growth in emerging markets. However, some central nervous system (CNS) drugs market restraints include patent expiration of branded central nervous system drugs. request a sample here

What is the forecast market size of the central nervous system drugs market?

The central nervous system (CNS) drugs market forecast is expected to reach $163.05 billion in 2025 at a compound annual growth rate of 6%. request a sample here

How is the central nervous system drugs market segmented?

The global central nervous system drugs market is segmented -
1) By Type: Analgesics, Anti-Parkinson drugs, Anesthetics, Anti-Epileptics, Other CNS drugs
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route Of Administration: Oral, Parenteral, Others
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs request a sample here

Which region has largest share, and what is the market size and growth by geography according to the central nervous system drugs global market report?

For more detail on this, request a sample here.

Who are the key players of the global central nervous system drugs market?

Top competitors in the central nervous system (CNS) drugs market are Biogen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Pfizer Inc, Novartis AG. request a sample here.

What are the key trends in the global central nervous system drugs market?

Major trends influencing the central nervous system (CNS) drugs market include collaboration with other manufacturers in the industry to share technical knowledge and improve product quality request a sample here.

What are the major opportunities in the central nervous system drugs market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global central nervous system drugs market, request a sample here.

How does the central nervous system drugs market relate to the overall economy and other similar markets?

request a sample here.